CVEvulnerability

CVE-2021-26726

8.8 HIGH Published 2022-02-16 Modified 2026-06-17 Official page ↗
Status
Modified
Published
2022-02-16
Last modified
2026-06-17
Assigner
[email protected]
CVSS 3.1 ([email protected])
8.8 HIGH — CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS 3.1 ([email protected])
8.8 HIGH — CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS 2.0 ([email protected])
8.3 HIGH — AV:A/AC:L/Au:N/C:C/I:C/A:C
Weaknesses
CWE-209, CWE-272, CWE-305, CWE-330, CWE-78

Description

A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021.

Affected configurations

• valmet dna (>= 2012 <= 2021)

Related

Weakness · CWE (5)

  • CWE-209 Generation of Error Message Containing Sensitive Information weakness
  • CWE-272 Least Privilege Violation weakness
  • CWE-305 Authentication Bypass by Primary Weakness weakness
  • CWE-330 Use of Insufficiently Random Values weakness
  • CWE-78 Improper Neutralization of Special Elements used in an OS Command weakness

References